These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35904048)

  • 1. Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC).
    Hamo CE; Echouffo-Tcheugui JB; Zhang S; Florido R; Pankow JS; Michos ED; Goldberg R; Nambi V; Gerstenblith G; Post WS; Blumenthal RS; Ballantyne C; Selvin E; Coresh J; Ndumele CE
    Clin Chem; 2022 Oct; 68(10):1272-1280. PubMed ID: 35904048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study.
    McEvoy JW; Lazo M; Chen Y; Shen L; Nambi V; Hoogeveen RC; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
    Int J Cardiol; 2015; 187():651-7. PubMed ID: 25880403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Lifestyle Factors and Life's Simple 7 Score to Temporal Reduction in Troponin Levels Measured by a High-Sensitivity Assay (from the Atherosclerosis Risk in Communities Study).
    Fretz A; McEvoy JW; Rebholz CM; Ndumele CE; Florido R; Hoogeveen RC; Ballantyne CM; Selvin E
    Am J Cardiol; 2018 Feb; 121(4):430-436. PubMed ID: 29268937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.
    Whelton SP; McEvoy JW; Lazo M; Coresh J; Ballantyne CM; Selvin E
    Diabetes Care; 2017 Feb; 40(2):261-269. PubMed ID: 28108537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults.
    Myhre PL; Claggett B; Ballantyne CM; Selvin E; Røsjø H; Omland T; Solomon SD; Skali H; Shah AM
    JAMA Cardiol; 2019 Oct; 4(10):997-1006. PubMed ID: 31483438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, subclinical myocardial injury, and incident heart failure.
    Ndumele CE; Coresh J; Lazo M; Hoogeveen RC; Blumenthal RS; Folsom AR; Selvin E; Ballantyne CM; Nambi V
    JACC Heart Fail; 2014 Dec; 2(6):600-7. PubMed ID: 25443112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight History and Subclinical Myocardial Damage.
    Ndumele CE; Cobb L; Lazo M; Bello NA; Shah A; Nambi V; Blumenthal RS; Gerstenblith G; Solomon SD; Ballantyne CM; Selvin E; Coresh J
    Clin Chem; 2018 Jan; 64(1):201-209. PubMed ID: 29158254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.
    Pokharel Y; Sun W; Virani SS; Nambi V; Hoogeveen RC; Chang PP; Ndumele CE; Solomon SD; Bozkurt B; Selvin E; Ballantyne CM; Deswal A
    JACC Heart Fail; 2017 Jan; 5(1):56-63. PubMed ID: 28017350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage.
    Selvin E; Lazo M; Chen Y; Shen L; Rubin J; McEvoy JW; Hoogeveen RC; Sharrett AR; Ballantyne CM; Coresh J
    Circulation; 2014 Oct; 130(16):1374-82. PubMed ID: 25149362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Sensitivity Cardiac Troponin T and Risk of Hypertension.
    McEvoy JW; Chen Y; Nambi V; Ballantyne CM; Sharrett AR; Appel LJ; Post WS; Blumenthal RS; Matsushita K; Selvin E
    Circulation; 2015 Sep; 132(9):825-33. PubMed ID: 26152706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of High-Sensitivity Cardiac Troponin Assays to Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes.
    Tang O; Daya N; Matsushita K; Coresh J; Sharrett AR; Hoogeveen R; Jia X; Windham BG; Ballantyne C; Selvin E
    Diabetes Care; 2020 Jun; 43(6):1200-1208. PubMed ID: 32161049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Socioeconomic Status With Subclinical Myocardial Damage, Incident Cardiovascular Events, and Mortality in the ARIC Study.
    Fretz A; Schneider AL; McEvoy JW; Hoogeveen R; Ballantyne CM; Coresh J; Selvin E
    Am J Epidemiol; 2016 Mar; 183(5):452-61. PubMed ID: 26861239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol, With Subclinical Cardiovascular Disease.
    Liang M; McEvoy JW; Chen Y; Sharrett AR; Selvin E
    Diabetes Care; 2016 Oct; 39(10):1752-9. PubMed ID: 27481841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-year change in high sensitivity cardiac troponin T and the risk of atrial fibrillation in the Atherosclerosis Risk in Communities cohort.
    Li L; Selvin E; Hoogeveen RC; Soliman EZ; Chen LY; Norby FL; Alonso A
    Clin Cardiol; 2021 Nov; 44(11):1594-1601. PubMed ID: 34545585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
    Juraschek SP; Daya N; Appel LJ; Miller ER; Matsushita K; Michos ED; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
    McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
    JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults.
    Tang O; Matsushita K; Coresh J; Hoogeveen RC; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2021 Apr; 69(4):986-994. PubMed ID: 33150614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).
    Seliger SL; Hong SN; Christenson RH; Kronmal R; Daniels LB; Lima JAC; de Lemos JA; Bertoni A; deFilippi CR
    Circulation; 2017 Apr; 135(16):1494-1505. PubMed ID: 28159799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis.
    Parikh RH; Seliger SL; de Lemos J; Nambi V; Christenson R; Ayers C; Sun W; Gottdiener JS; Kuller LH; Ballantyne C; deFilippi CR
    Clin Chem; 2015 Dec; 61(12):1524-31. PubMed ID: 26506994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.